menu
    • menu

    Company profile for Imbria Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Imbria, we are using our deep understanding of energy metabolism to develop novel therapies designed to substantially improve the lives of patients with life-altering diseases. Our clinical stage pipeline is focused on restoring or improving the cell’s ability to produce energy in disorders where energetic impairment is a fundamental contributor, including cardiovascular disease and specific inborn errors in metabolism. ...
    At Imbria, we are using our deep understanding of energy metabolism to develop novel therapies designed to substantially improve the lives of patients with life-altering diseases. Our clinical stage pipeline is focused on restoring or improving the cell’s ability to produce energy in disorders where energetic impairment is a fundamental contributor, including cardiovascular disease and specific inborn errors in metabolism. Our lead program, IMB-101, is currently in Phase 2 clinical development in three indications: Hypertrophic cardiomyopathy, stable angina, and type 2 diabetes at risk for diabetic cardiomyopathy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Imbria PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    265 Franklin Street, Suite #1702 Boston, MA 02110
    Telephone
    Telephone
    617-675-4060
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://imbria.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/imbria/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Imbria hits goal in angina trial days after heart failure win
    Imbria hits goal in angina trial days after heart failure win

    13 Nov 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/imbria-goes-2-2-hitting-safety-goal-angina-trial-days-after-racking-heart-failure-win

    Nick Paul Taylor FIERCE BIOTECH
    13 Nov 2023
    Share Share
    Imbria touts PhII success in hypertrophic cardiomyopathy
    Imbria touts PhII success in hypertrophic cardiomyopathy

    08 Nov 2023

    // ENDPTS

    https://endpts.com/imbria-touts-phii-success-in-hypertrophic-cardiomyopathy-adding-fuel-to-overall-efficacy-profile/

    ENDPTS
    08 Nov 2023
    Share Share
    Imbria hits safety benchmark in phase 2 heart failure test
    Imbria hits safety benchmark in phase 2 heart failure test

    07 Nov 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/imbria-hits-safety-benchmark-phase-2-heart-failure-test-early-efficacy-data-buoy-late-stage

    Annalee Armstrong FIERCE BIOTECH
    07 Nov 2023
    Share Share
    Imbria Pharmaceuticals Appoints John Young to Its Board of Directors
    Imbria Pharmaceuticals Appoints John Young to Its Board of Directors

    24 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220324005189/en

    BUSINESSWIRE
    24 Mar 2022
    Share Share
    Imbria Pharma to Participate at SVB Leerink Biopharma Private Company Connect
    Imbria Pharma to Participate at SVB Leerink Biopharma Private Company Connect

    22 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220322006167/en

    BUSINESSWIRE
    22 Mar 2022
    Share Share
    Imbria Announces Initiation of Enrollment in IMPROVE-HCM
    Imbria Announces Initiation of Enrollment in IMPROVE-HCM

    19 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210719005105/en

    BUSINESSWIRE
    19 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search